References
World Health Organization Weekly epidemiological record, 8 September 2017; 92(36):521–536
Sack DA, Sack RB, Chaignat CL (2006) Getting serious about cholera. N Engl J Med 355(7):649–651
Livermore DM, Tulkens PM (2009) Temocillin revived. J Antimicrob Chemother 63(2):243–245
De Jongh R, Hens R, Basma V, Mouton J, Tulkens P, Carryn S (2008) Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 61(2):382–388
Bier N, Schwartz K, Guerra B, Strauch E (2015) Survey on antimicrobial resistance patterns in Vibrio vulnificus and Vibrio cholerae non-O1/non-O139 in Germany reveals carbapenemase-producing Vibrio cholerae in coastal waters. Front Microbiol 6:1179
Dengo-Baloi LC, Sema-Baltazar CA, Manhique LV, Chitio JE, Inguane DL, Langa JP (2017) Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015. PLoS One 12 (8):e0181496
Funding
This investigation was funded by Belpharma S.A., Luxembourg.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
MR and MM have received sponsorship from Belpharma to attend scientific meetings. SVDV is an employee of Eumedica s.a. RS and MRF declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rahbar, M., Saboorian, R., Van de Velde, S. et al. Activity of temocillin and comparators against clinical isolates of Vibrio cholerae from Iran. Eur J Clin Microbiol Infect Dis 38, 615–616 (2019). https://doi.org/10.1007/s10096-019-03483-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-019-03483-5